INTERIM SAFETY AND EFFICACY OF VOXELOTOR IN CHILDREN AGED 2 to <4 YEARS WITH SICKLE CELL DISEASE

被引：0
|
作者：
Fuh, Beng [1 ]
Inati, Adlette [1 ]
Inusa, Baba [1 ]
Abboud, Miguel [1 ]
Norris, Cynthia [1 ]
Kalpatthi, Ramasubramanian [1 ]
Telfer, Paul [1 ]
Trompeter, Sara [1 ]
Dixon, Sandy [1 ]
Enriquez, Aimee [1 ]
Akhlaghi, Fatemeh [1 ]
Smith-Whitley, Kim [1 ]
Brown, Clark [1 ]
机构：
[1] East Carolina Univ, Brody Sch Med, Greenville, NC USA
来源：
PEDIATRIC BLOOD & CANCER | 2023年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
378
引用
收藏
页码：S163 / S164
页数：2
相关论文
共 50 条
  • [1] Safety and efficacy of voxelotor in pediatric patients with sickle cell disease aged 4 to 11 years
    Estepp, Jeremie H.
    Kalpatthi, Ram
    Woods, Gerald
    Trompeter, Sara
    Liem, Robert I.
    Sims, Kacie
    Inati, Adlette
    Inusa, Baba P. D.
    Campbell, Andrew
    Piccone, Connie
    Abboud, Miguel R.
    Smith-Whitley, Kim
    Dixon, Sandra
    Tonda, Margaret
    Washington, Carla
    Griffin, Noelle M.
    Brown, Clark
    [J]. PEDIATRIC BLOOD & CANCER, 2022, 69 (08)
  • [2] REAL-WORLD EFFECTIVENESS OF VOXELOTOR IN CHILDREN WITH SICKLE CELL DISEASE AGED 4 TO <18 YEARS
    Shah, Nirmish
    Lipato, Thokozeni
    Delea, Thomas
    Lonshteyn, Alexander
    Weycker, Derek
    Nguyen, Andy
    Beaubrun, Anne
    Alvarez, Ofelia
    [J]. PEDIATRIC BLOOD & CANCER, 2023, 70 : S159 - S160
  • [3] Efficacy and Safety of Voxelotor in Sickle Cell Disease: A Systematic Review
    Ali, Muhammad Ashar
    Khan, Anam
    Khan, Sana Irfan
    Aamir, Sobia
    Rahman, Saad Ur
    Waqar, Anum
    Chaudry, Hafsa Tahir
    Anwar, Muhammad Yasir
    Aiman, Wajeeha
    Anwer, Faiz
    [J]. BLOOD, 2020, 136
  • [4] Voxelotor in sickle cell disease
    Bain, Barbara J.
    Myburgh, Jane
    Hann, Amanda
    Layton, D. Mark
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (06) : 830 - 832
  • [5] SAFETY AND EFFICACY OF 4 YEARS OF DEFERASIROX TREATMENT FOR SICKLE CELL DISEASE PATIENTS
    Vlachaki, Efthymia
    Mainou, Maria
    Bekiari, Eleni
    Vetsiou, Evaggelia
    Tsapas, Apostolos
    [J]. HEMOGLOBIN, 2013, 37 (01) : 94 - 100
  • [6] VOXELOTOR IN CHILDREN WITH SICKLE CELL ANEMIA: EFFICACY AND IMPROVEMENT IN ERYTHROCYTE PHYSIOLOGY
    Chonat, Satheesh
    Fields, Earl
    Baratz, Hannah
    Watt, Amanda
    Pochron, Mira
    Dixon, Sandy
    Tonda, Margaret
    Lehrer-Graiwer, Joshua
    Brown, Clark
    Archer, David
    [J]. PEDIATRIC BLOOD & CANCER, 2020, 67 : S40 - S40
  • [7] Case report: Safety and efficacy of voxelotor in a patient with sickle cell disease and stage IV chronic kidney disease
    Alshurafa, Awni
    Yassin, Mohamed A. A.
    [J]. FRONTIERS IN MEDICINE, 2022, 9
  • [8] Voxelotor for the treatment of sickle cell disease
    Vissa, Madhav
    Vichinsky, Elliott
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2021, 14 (03) : 253 - 261
  • [9] Efficacy and Safety of Voxelotor in Adolescents and Adults with Sickle Cell Disease: HOPE Trial 72-Week Analysis
    Howard, Jo
    Ataga, Kenneth I.
    Brown, R. Clark
    Achebe, Maureen
    Nduba, Videlis
    El-Beshlawy, Amal
    Hassab, Hoda
    Agodoa, Irene
    Tonda, Margaret
    Gray, Sarah
    Lehrer-Graiwer, Joshua
    Vichinsky, Elliott
    [J]. BLOOD, 2020, 136
  • [10] Voxelotor: A Novel Treatment for Sickle Cell Disease
    Herity, Leah B.
    Vaughan, DaleMarie M.
    Rodriguez, Lindsey Ftitenour
    Lowe, Denise Kozella
    [J]. ANNALS OF PHARMACOTHERAPY, 2021, 55 (02) : 240 - 245
12345